Freezing breast cancer: new registry follows Patients' outcomes
NCT ID NCT06387173
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is a registry that tracks side effects and outcomes in people who have undergone cryoablation (freezing) for early stage breast cancer. It is not testing a new treatment but rather collecting real-world data on symptoms, complications, and follow-up results. Only 2 participants are enrolled, so the information gathered is very limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY STAGE BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Strawberry compound and exercise may keep breast cancer survivors from becoming frail
- New radiation approach aims to cut treatment time for early breast cancer
- Could a simple TENS device ease chemo nerve pain?
- Can acupuncture soothe Chemo's nerve pain? small study hints yes
- Could one radiation dose before breast surgery replace weeks of treatment?
- Simple breathing exercises could ease chemo side effects for breast cancer patients